Serotonergic ependymal fibres in rat and monkey: Light and electron microscopic immunocytochemical study

Biocell

Volumn 22, Issue 2, 1998, Pages 115-122

  Brusco, A ^a   Lopez Costa J J ^a   Tagliaferro, P ^a   Pecci Saavedra, J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Ependymal; Immunocytochemistry; Monkey; Rat; Serotonin

Indexed keywords

ANIMAL TISSUE; ARTICLE; DEPRESSION; ELECTRON MICROSCOPY; EPENDYMA; MICROSCOPY; MONKEY; NERVE FIBER; NONHUMAN; RAT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC NERVE; SUICIDE;

ANIMALS; CEBUS; EPENDYMA; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; NERVE FIBERS; RABBITS; RATS; RATS, WISTAR; SEROTONIN;

ANIMALIA;

EID: 0031752231     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. AGHAJANIAN GK, GALLAGER DW (1975). Raphe origin of serotonergic nerves terminating in the cerebral ventricles. Brain Res 88: 221-231.
2. BEAUDET A, DESCARRIES L (1976). Quantitative data on serotonin nerve terminals in adult rat neocortex. Brain Res 111: 301-309.
3. BRIGHTMAN MW, PALAY SL (1963). The fine structure of ependyma in the brain of the rat. J Cell Biol 19: 415-439.
4. BRUSCO A, PERESSINI S, PECCI SAAVEDRA J (1983). Serotonin-like immunoreactivity and anti-5-hydroxytryptamine (5HT) antibodies: ultrastructural application in the central nervous system. J Histochem Cytochem 31: 524-530.
5. BRUSCO A, CANESSA O, TAGLIAFERRO P, PECCI SAAVEDRA J (1993). Efectos de la paraclorofenilalanina sobre las neuronas indolaminérgicas. Sociedad Argentina de Farmacología Experimental. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana. pp 80. Abs 23.
6. CHAN-PALAY V (1976). Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; their roles in local alterations of cerebrospinal fluid and vasomotor activity. Brain Res 112: 103-130.
7. CLEARE AJ, BEARN J, ALLAIN T, MC GREGOR A, WESSELY S, MURRAY R, O'KEANE V (1995). Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 34(4): 283-289.
8. DÄHLSTROM A, FUXE K (1964a). Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta Physiol Scand 62 Suppl 232: 1-55.
9. DÄHLSTROM A, FUXE K (1964b). A method for the demonstration of monoamine-containing nerve fibers in the central nervous system. Acta Physiol Scand 60: 293-294.
10. DESCARRIES L, AUDET MA, DOUCET G, GARCÍA S, OLESKEVICH S, SEGUELA P, SOGHOMONIAN JJ, WATKINS KC (1990). Morphology of central serotonin neurons: brief review of quantified aspects of their distribution and ultrastructural relationships. Ann NY Acad Sci 600: 81-92.
11. DINOPOULOS A, DORI I (1995). The development of the serotonergic fiber network of the lateral ventricles of the rat brain: a light and electron microscopic immunocytochemical analysis. Exp Neurol 133(1): 73-84.
12. EVANGELISTA DE DUFFARD AM, BRUSCO A, DUFFARD R, GARCÍA G, PECCI SAAVEDRA J (1995). Changes in serotonin-immunoreactivity in the dorsal and median raphe nucleus of rats exposed to 2,4-dichlorophenoxyacetic acid through lactation. Mol Chem Neuropathol 26: 187-193.
13. FALCK B, HILLARP NA, THIEME G, TORP A (1962). Fluorescence of catecholamines and related compounds with formaldehyde. J Histochem Cytochem 10: 348-354.
14. FAUSTMAN WO, KING RJ, FAULL KF, MOSES JA JR., BENSON KL, ZARCONE VP, CSERNASKY JG (1991). MMPI measures of impulsivity and depression correlate with CSF-5HIAA and HVA in depression but not schyzophrenia. J Affect Disord 22: 235-139.
15. FELDBERG W, MYERS RD (1966). Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles. J Physiol (Lond.) 184: 837-855
16. FUXE K, JOHNSSON G (1974). Further mapping of central 5-hydroxytryptamine containing neurons: studies with the neurotoxic dihydroxytryptamine. In: Advances in Biochem. Pharmacol. Vol. 10. E. Costa, G.L. Gessa and M. Sandler, Eds. Raven Press. New York, pp. 1-12.
17. HIRUNAGI K, ISHIKAWA A, NAMIKAWA T, URYU K (1995). Immunocytochemical identification of serotonergic supraependymal nerve fibres in the third ventricle of the house musk shrew, Suncus marinus. Anat Anz 177(4): 297-304.
18. IMAI H, KIMURA H, MAEDA T (1982). A stable and simple method of Faglupagas fixation or catecholamines for routine examination. Acta Histochem Cytochem 15: 798-806.
19. ISSA F, GERHARDT GA, BARTKO JJ, SUDDATH RL, LYNCH M, GAMACHE PH, FREEDMAN R, WYATT RJ, KIRCH DG (1994). Multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schyzophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses. Psychiatry Res 52(3): 237-249.
20. KATZ MM, MAAS JW, FRAZER A, KOSLOW SH, BOWDEN CL, BERMAN N, SWANN AC, STOKES PE (1994). Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology 11(2): 89-100.
21. KOPONEN HJ, LEPOLA U, LEINONEN E (1994). A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium. Eur Arch Psychiatry Clin Neuropsy 244(3): 131-134.
22. LESTER D (1995). The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: A meta-analysis. Pharmacopsychiatry 28(2): 45-50.
23. LOREZ HP, RICHARDS JG (1973). Distribution of indolealkylamine nerve terminals in the ventricles of the rat brain. Z Zellforsch 144: 511-522.
24. MAES M, MELTZER HY (1995). The serotonin hypothesis of major depression. In Psychopharmacology: The Fourth Generation of Progress. Bloom and Kupfer, Eds. Reven Press Ltd. NY, chapter 81: 933-944.
25. NORDSTROM P, SAMUELSSON M, ASBERG M, TRAKMAN-BENDZ L, ABERG-WISTEDT A, NORDIN C, BERTILSSON L (1994). CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav., Spring 24(1): 1-9.
26. NUTT DJ, WILSON SJ, COUPLAND NJ (1995). Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders. Int Clin Psycopharmacol 9 (Suppl 4): 53-59.
27. PASPALAS CD, PAPADOPOULOS GC, MICHALOUDI H (1994). Serotonin supraependymal plexus in the ventricular system of the hedgehog: organization principles and functional implications. J Himforsch 35(3): 333-342.
28. PECCI SAAVEDRA J, BRUSCO A, PERESSINI S (1982a). Immunocytochemical study of synaptic connectivities of the raphe neurons: the possible presynaptic role of dendrites. Com Biol 1: 189-197.
29. PECCI SAAVEDRA J, BRUSCO A, OLIVA DE, PERESSINI S (1982b). Fibras serotoninérgicas ependimarias. Proc. of Sociedad Argentina de Farmacología Experimental, Mar del Plata, Argentina.
30. PECCI SAAVEDRA J, PASIK T, PASIK P (1983a). Immunocytochemistry of serotonergic neurons in the central nervous system of monkeys. In: Neuronal Transmission, Learning and Memory. R. Caputto and C. Ajmone Marsan, Eds. Raven Press. New York. Ch. 7, pp 81-96.
31. PECCI SAAVEDRA J, BRUSCO A, TANDLER CJ (1983b). Tetrahydro-β-carboline as the true immunogen in the production of anti-5HT-like antibodies. Com Biol 2: 49-59.
32. PECCI SAAVEDRA J, TAGLIAFERRO P, RAMOS A, LÓPEZ EM, BRUSCO A (1996). Neuronal and glial changes following chronic parachlorophenylalanine (PCPA) administration. IV World Conference on Clinical Pharmacology and Therapeutics, Buenos Aires, Argentina. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, pp 165. Abs 708.
33. PERESSINI S, BRUSCO A, PECCI SAAVEDRA J (1984). Basis for the specificity of anti-5HT-like antisera in immunocytochemistry of the central nervous system. Histochemistry 80: 597-602.
34. PORTER JC, KAMBERI YA, ONDO JG (1972). Role of biogenic amines and cerebrospinal fluid in neurovascular transmittal of hypophysiotrophic substances. In: K.M. Knigge, D.E. Scott and A. Weindl, Eds. Brain-Endocrine Interaction. Median Eminence: Structure and Function, Int. Symposium, Munich, Karger, Basel, pp. 245-253.
35. PRIESTLEY JV, ALVAREZ FJ, AVERILL S (1992). Pre-embedding electron microscopic immunocytochemistry. In: Electron microscopic immunocytochemistry. J.M. Polak, J.V. Priestley, Eds. Oxford University Press, Oxford, pp. 89-121.
36. RICHARDS JG, LOREZ HP, TRANZER JP (1973). Indolealkylamine nerve terminals in cerebral ventricles: Identification by electron microscopy and fluorescence histochemistry. Brain Res 57: 277-288.
37. RICHARDS J, TRANZER JP (1974). Ultrastructural evidence for the localization of an indolealkylamine in supraependymal nerves from combined cytochemistry and pharmacology. Experientia (Basel) 30: 287-289.
38. STEINBUSH HWM (1981). Distribution of serotonin immunoreactivity in the central nervous system of the rat: cell bodies and terminals. Neuroscience 6: 557-618.
39. STERNBERGER LA, HARDY JR. PH, CUCULIS JJ, MEYER HG (1970). The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochets. J Histochem Cytochem 18: 315-333.
40. TANDLER A, BRUSCO A, PECCI SAAVEDRA J (1986). Further evidence for the specificity of anti-5HT (serotonin)-like antisera in immunocytochemistry. Histochemistry 85: 67-72.
41. TOHGI H, ABE T, TAKAHASHI S, SAHEKI M, KIMURA M (1995). Indolamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J Neural Transm Park Dis Dement Sect 9(2-3): 121-131.
42. WESTERGAARD E (1972). The fine structure of nerve fibers and endings in the lateral cerebral ventricles of the rat. J Comp Neurol 144: 345-354.
43. YI YH, LIAO WP, LU X (1994). Simultaneous determination of tryptophan, 5-hydroxytryptophan, 5-hydroxytrytamine, 5-hydroxyindoleacetic acid, 4-hydroxy-3-methoxyphenylacetic acid and 3-methoxy-4-hydroxyphenylglycol in human cerebrospinal fluid. J Chromatogr B Biomed Applied 661(1): 143-148.